The Arteriovenous Vascular (AV) ACCESS Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.
Also called NCT04646226
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 103 participants
- Registry
-
NCT04646226
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04646226. Randomized; no masking; primary purpose treatment. Start 2022-08-18 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Arteriovenous Vascular (AV) ACCESS Trial
- Condition
- End-Stage Kidney Disease
- Condition
- Hemodialysis Complication
- Intervention (Device)
- AV graft
- Intervention (Procedure)
- surgical intervention for creation of a fistula
- Lead sponsor
- Wake Forest University Health Sciences
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct04646226- Content hash
2430ff8a83b00a68b912eac006b851d7c64fdfacab9cf3f60009e930a5f6d916